Valuation : Diaceutics PLC

Market Cap 13Cr 17Cr 15Cr 14Cr 24Cr 1.61TCr 24Cr 163.72Cr 63Cr 826.78Cr 64Cr 63Cr 2.63TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 12Cr 16Cr 14Cr 13Cr 22Cr 1.51TCr 22Cr 153.62Cr 59Cr 775.75Cr 60Cr 59Cr 2.47TCr EV / Sales 2026 *
2.53x
EV / Sales 2027 * 2.02x
Free-Float
71.97%
Yield 2026 *
-
Yield 2027 * -
1 day-2.44%
6 months+19.76%
Current year+46.28%
Current year 1.67
Extreme 1.67
2.51
1 year 1.67
Extreme 1.67
2.51
3 years 1.67
Extreme 1.67
2.51
5 years 1.05
Extreme 1.05
2.51
10 years 1.05
Extreme 1.05
2.51
Manager TitleAgeSince
Chief Executive Officer 42 01/01/2024
Director of Finance/CFO - 18/03/2022
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 01/10/2024
Director/Board Member 42 -
Director/Board Member 42 01/10/2024
Change 5-day change 1-year change 3-year change Capi.($)
-2.44%-.--% - - 17Cr
+10.03%+24.46%+287.69%+1,141.78% 6.21TCr
-1.99%+1.61% - - 606.74Cr
+10.58%+15.08% - - 342.74Cr
-2.36%-2.08%-20.43%+38.05% 347.41Cr
-1.47%-2.86%-11.24%+110.03% 322.62Cr
+2.36%+0.38% - - 300.27Cr
-2.51%-1.55%-18.21%-25.28% 152.3Cr
+5.58%+8.50%-41.59%+34.95% 132.91Cr
Average +2.02%+2.34%+39.24%+259.91% 1.05TCr
Weighted average by Cap. +7.89%+6.39%+246.66%+996.37%

Financials

2026 *2027 *
Net sales 4.67Cr 6.33Cr 5.44Cr 5.12Cr 8.74Cr 598.4Cr 8.77Cr 61Cr 23Cr 306.44Cr 24Cr 23Cr 976.1Cr 5.63Cr 7.63Cr 6.56Cr 6.17Cr 11Cr 721.66Cr 11Cr 73Cr 28Cr 369.56Cr 29Cr 28Cr 1.18TCr
Net income -11L -14.9L -12.81L -12.05L -20.57L -14Cr -20.64L -1.43Cr -55.23L -7.22Cr -55.95L -54.72L -23Cr 15L 20.32L 17.47L 16.43L 28.05L 19Cr 28.14L 1.95Cr 75.31L 9.84Cr 76.29L 74.62L 31Cr
Net Debt -77.8L -1.05Cr -90.62L -85.23L -1.46Cr -100Cr -1.46Cr -10Cr -3.91Cr -51Cr -3.96Cr -3.87Cr -162.56Cr -1.21Cr -1.64Cr -1.41Cr -1.33Cr -2.26Cr -154.94Cr -2.27Cr -16Cr -6.07Cr -79Cr -6.15Cr -6.02Cr -252.74Cr
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.485GBP
Average target price
2.130GBP
Spread / Average Target
+43.43%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!